AMCOR PLC AMCR 深 沪
等待开盘 07-02 09:30:00 美东时间
43.64
+0.290
+0.67%
华盛通- 最 高44.29
- 今 开43.35
- 成交量 336.49万股
- 最 低 43.13
- 昨 收 43.35
- 总市值 2017.68万
- 52周最高 49.64
- 市盈率 静 27.26
- 换手率 0.73%
- 52周最低 35.60
- 委 比 -84.44%
- 总股本 0.00亿
- 历史最高 57.975
- 量 比 1.00
- 振 幅 2.68%
- 历史最低 11.9125
- 每 手 1
- 风险率 3.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Amcor Collaborates With Kelpi To Explore Next-Gen Coating Technologies To Enhance Performance And Sustainability Of Packaging Materials
Amcor (NYSE:AMCR, ASX: AMC))), a global leader in developing and producing responsible packaging solutions, today announced a collaboration with U.K.-based startup Kelpi to explore next-generation coating technologies designed to enhance the performance and sustainability of packaging materials. The...
06-29 23:32
美股大行评级 | Cava、CrowdStrike、Keysight获多家大行上调目标价；家得宝绩后遭多家大行下调目标价
今日重点评级关注：Oppenheimer：维持Protara Therapeutics"跑赢大市"评级，目标价从25美元升至28美元；Piper Sandler：维持Bright Minds Biosciences"超配"评级，目标价从190美元升至220美元
05-21 12:05
Wells Fargo Maintains Equal-Weight on Amcor, Lowers Price Target to $41
Wells Fargo analyst Gabe Hajde maintains Amcor (NYSE:AMCR) with a Equal-Weight and lowers the price target from $43 to $41.
05-20 21:34
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
财报速睇 | AMCOR PLC 2026财年Q1营收59.14亿美元，同比增长77.4%；归母净利润2.78亿美元，同比增长41.8%
华盛资讯5月7日讯，AMCOR PLC公布2026财年Q1业绩，公司Q1营收59.14亿美元，同比增长77.4%，归母净利润2.78亿美元，同比增长41.8%。
05-07 19:06
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
财报速睇 | AMCOR PLC 2026财年Q1营收59.14亿美元，同比增长77.4%；归母净利润2.78亿美元，同比增长41.8%
华盛资讯5月6日讯，AMCOR PLC公布2026财年Q1业绩，公司Q1营收59.14亿美元，同比增长77.4%，归母净利润2.78亿美元，同比增长41.8%。
05-06 18:52
Amcor Lowers FY2026 Adj EPS Guidance from $4.00-$4.15 to $3.98-$4.03 vs $3.96 Est
Fiscal 2026 Guidance:•Adjusted EPS $3.98 to $4.03, growth of ~12% at the midpoint; Mitigating impact of Middle East conflict•Free Cash Flow revised to be $1.5-1.6 billion
05-06 18:12
Amcor Q3 Adj. EPS $0.96 Misses $0.97 Estimate, Sales $5.914B Beat $5.689B Estimate
Amcor (NYSE:AMCR) reported quarterly earnings of $0.96 per share which missed the analyst consensus estimate of $0.97 by 1.03 percent. This is a 6.67 percent increase over earnings of $0.90 per share from the same period
05-06 18:11
Closure Systems International Acquires Two Beverage Closure Compression Molding Sites From Amcor In Pennsylvania, Mississippi; Financial Terms Undisclosed
Closure Systems International ("CSI"), a global leader in closure solutions, today announced the acquisition of two beverage closure compression molding facilities from Amcor (NYSE:AMCR, ASX:AMC)), a global leader in
05-06 04:56
